Biomedical methods for HIV prevention: new setbacks.
Laurence
Jeffrey
J
D016915:AIDS Vaccines; D000282:Administration, Intravaginal; D000818:Animals; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage; D044966:Anti-Retroviral Agents / Q000008:administration & dosage / Q000494:pharmacology; D023241:Antiretroviral Therapy, Highly Active; D002986:Clinical Trials as Topic; D017280:Condoms; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D005260:Female; D014943:Global Health; D006678:HIV / Q000502:physiology*; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D008297:Male; D021841:Safe Sex; D016896:Treatment Outcome; D053585:Virus Attachment / Q000187:drug effects
D016915:AIDS Vaccines; D000891:Anti-Infective Agents, Local; D044966:Anti-Retroviral Agents